Key Takeaways
- • IPEX trades near par with minimal activity: Inflection Point Acquisition Corp. V closed at $10.54 on July 29, 2026, unchanged on the day with light trading volume of 9,957 shares, significantly below its 12,977-share average daily volume.
- • Shell company structure with acquisition mandate: IPEX is a blank-check acquisition vehicle incorporated in 2024 that rebranded from Maywood Acquisition Corp. in November 2025; the entity has no significant operations and is seeking a merger, asset acquisition, or similar business combination.
- • Underperformance versus broader market: IPEX has delivered a year-to-date return of 2.53% and one-year return of 3.71%, materially lagging the S&P 500's 6.88% YTD and 14.84% one-year performance, reflecting typical SPAC near-NAV trading dynamics.
- • Technical positioning near support and resistance: The stock maintains support at $9.96 while approaching resistance near $11.00, with a 52-week range of $10.08 to $10.55, indicating tight consolidation typical of pre-deal SPACs.
- • Market capitalization of $125.5 million: IPEX's current intraday market cap reflects a small-cap SPAC profile with limited institutional trading activity.
Summary
Inflection Point Acquisition Corp. V (IPEX) edged higher in light trading as of late July 2026, closing at $10.54 with minimal price movement and below-average trading volume of approximately 9,957 shares. The stock's near-par valuation reflects the typical risk profile of blank-check acquisition vehicles that have not yet completed a business combination.
IPEX operates as a shell company with no significant operating business. The entity was incorporated in 2024 and renamed from Maywood Acquisition Corp. in November 2025. As a SPAC structure, the company is mandated to effect a merger, asset acquisition, share exchange, or similar business combination with one or more operating businesses. The company is based in New York and listed on the Nasdaq.
From a performance perspective, IPEX has significantly underperformed the broader equity market. As of July 29, 2026, the stock delivered a year-to-date return of 2.53% compared to the S&P 500's 6.88%, and a one-year return of 3.71% versus the benchmark's 14.84%. This underperformance is consistent with typical SPAC trading patterns, where units remain anchored near their redemption value pending deal announcement. The stock's 52-week range of $10.08 to $10.55 reflects minimal volatility and tight consolidation, with technical support identified near $9.96 and resistance approaching $11.00.
IPEX's light trading activity and par-adjacent pricing suggest limited institutional interest ahead of a potential business combination announcement. With a market capitalization of $125.525 million and a PE ratio of 1,054 based on minimal trailing twelve-month earnings of $0.01, valuation metrics are largely irrelevant until operational results materialize post-deal.
IPEX operates as a shell company with no significant operating business. The entity was incorporated in 2024 and renamed from Maywood Acquisition Corp. in November 2025. As a SPAC structure, the company is mandated to effect a merger, asset acquisition, share exchange, or similar business combination with one or more operating businesses. The company is based in New York and listed on the Nasdaq.
From a performance perspective, IPEX has significantly underperformed the broader equity market. As of July 29, 2026, the stock delivered a year-to-date return of 2.53% compared to the S&P 500's 6.88%, and a one-year return of 3.71% versus the benchmark's 14.84%. This underperformance is consistent with typical SPAC trading patterns, where units remain anchored near their redemption value pending deal announcement. The stock's 52-week range of $10.08 to $10.55 reflects minimal volatility and tight consolidation, with technical support identified near $9.96 and resistance approaching $11.00.
IPEX's light trading activity and par-adjacent pricing suggest limited institutional interest ahead of a potential business combination announcement. With a market capitalization of $125.525 million and a PE ratio of 1,054 based on minimal trailing twelve-month earnings of $0.01, valuation metrics are largely irrelevant until operational results materialize post-deal.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.